Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ross Murtagh"'
Autor:
Des Crowley, Gordana Avramovic, Walter Cullen, Collette Farrell, Anne Halpin, Mary Keevans, Eamon Laird, Tina McHugh, Susan McKiernan, Sarah Jayne Miggin, Ross Murtagh, Eileen O. Connor, Marie O’Meara, Deirdre O. Reilly, John S. Lambert
Publikováno v:
Archives of Public Health, Vol 79, Iss 1, Pp 1-9 (2021)
Abstract Background Prisoners are recognised as a high-risk population and prisons as high-risk locations for the transmission of hepatitis c virus (HCV) infection. Injecting drug use (IDU) is the main driver of HCV infection in prisoners and harm re
Externí odkaz:
https://doaj.org/article/44a3982162764c2f91cae634eb2b1add
Autor:
Desmond Crowley, Ross Murtagh, Walter Cullen, Mary Keevans, Eamon Laird, Tina McHugh, Susan McKiernan, Sarah Jayne Miggin, Eileen O’Connor, Deirdre O’Reilly, Graham Betts-Symonds, Ciara Tobin, Marie Claire Van Hout, John S. Lambert
Publikováno v:
Harm Reduction Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Abstract Background Hepatitis C Virus (HCV) infection is endemic in prison populations, and HCV management in prisons is suboptimal. Incarceration is a public health opportunity to target this cohort. Community peer support increases HCV screening an
Externí odkaz:
https://doaj.org/article/7938a31442bc45a488cc9088430097b3
Autor:
John S. Lambert, Ross Murtagh, Dee Menezes, Austin O’Carroll, Carol Murphy, Walter Cullen, Tina McHugh, Gordana Avramovic, Willard Tinago, Marie Claire Van Hout
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Hepatitis C virus (HCV) is one of the main causes of chronic liver disease worldwide. Prevalence of HCV in homeless populations ranges from 3.9 to 36.2%. The HepCheck study sought to investigate and establish the characterisation
Externí odkaz:
https://doaj.org/article/193c72c0508e4d27a895ff08e8707b82
Autor:
John S Lambert, Michael John Cook, John Eoin Healy, Ross Murtagh, Gordana Avramovic, Sin Hang Lee
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0209881 (2019)
The spirochetal bacterium Borrelia miyamotoi is a human pathogen and has been identified in many countries throughout the world. This study reports for the first time the presence of Borrelia miyamotoi in Ireland, and confirms prior work with the det
Externí odkaz:
https://doaj.org/article/54cc9bef52e443b9a6762c133749b393
Publikováno v:
COVID-19 ISBN: 9781849841481
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acae7b9f7a143e40e569e3cb75aebe62
https://doi.org/10.1183/2312508x.10024020
https://doi.org/10.1183/2312508x.10024020
Autor:
Shane D Falcinelli, Kayla W Kilpatrick, Jenna Read, Ross Murtagh, Brigitte Allard, Simon Ghofrani, Jennifer Kirchherr, Katherine S James, Erin Stuelke, Caroline Baker, JoAnn D Kuruc, Joseph J Eron, Michael G Hudgens, Cynthia L Gay, David M Margolis, Nancie M Archin
Publikováno v:
J Infect Dis
Background The replication-competent human immunodeficiency virus (HIV) reservoir is the major barrier to cure. The quantitative viral outgrowth assay (QVOA), the gold-standard method to quantify replication-competent HIV, is resource intensive, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3daab3321bce57c161e78dd6aace18de
https://doi.org/10.1093/infdis/jiaa718
https://doi.org/10.1093/infdis/jiaa718
Autor:
Brigitte Allard, David M. Margolis, Ross Murtagh, Katherine S James, Christian Gaebler, Jenna Read, Thiago Y. Oliveira, Shane D. Falcinelli, Jennifer Kirchherr, Marina Caskey, Caroline E. Baker, Julio C. C. Lorenzi, Elina Stoffel, Nancie M. Archin, Michel C. Nussenzweig, Victor A. Ramos, Jo Ann D. Kuruc, Robert F. Siliciano
Publikováno v:
Journal of Virology
The intact proviral DNA assay (IPDA) and quadruplex PCR (Q4PCR) represent major advances in accurately quantifying and characterizing the replication-competent HIV reservoir. This study compares the two novel approaches for measuring intact HIV provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e87f48e10ed8f6b11aca8626164e710
https://doi.org/10.1101/2020.10.07.330787
https://doi.org/10.1101/2020.10.07.330787
Autor:
Tina McHugh, Ciara Tobin, Marie Claire Van Hout, Walter Cullen, Graham Betts-Symonds, Susan McKiernan, Mary Keevans, D. Crowley, Sarah Jayne Miggin, John S. Lambert, Deirdre O’Reilly, Ross Murtagh, Eamon Laird, Eileen O'Connor
Publikováno v:
Harm Reduction Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Harm Reduction Journal
Harm Reduction Journal
Background Hepatitis C Virus (HCV) infection is endemic in prison populations, and HCV management in prisons is suboptimal. Incarceration is a public health opportunity to target this cohort. Community peer support increases HCV screening and treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aee5389e911b4d9faa63b61bd3eeb13
https://doi.org/10.1186/s12954-019-0313-7
https://doi.org/10.1186/s12954-019-0313-7
Autor:
Tina McHugh, Gordana Avramovic, Austin O'Carroll, Willard Tinago, Carol Murphy, Dee Menezes, Ross Murtagh, Walter Cullen, John S. Lambert, Marie Claire Van Hout
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Background Hepatitis C virus (HCV) is one of the main causes of chronic liver disease worldwide. Prevalence of HCV in homeless populations ranges from 3.9 to 36.2%. The HepCheck study sought to investigate and establish the characterisation of HCV bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37607b8ebff894070e8740b865e352a
https://doi.org/10.1186/s12879-019-3748-2
https://doi.org/10.1186/s12879-019-3748-2
Autor:
Valerie Jackson, David Le Blanc, Grainne McDonald, Marguerite Lawler, Laura Else, Niamh Redmond, Gordana Avramovic, Ross Murtagh, Saye Khoo, John S. Lambert, Kenneth Bk Kuan, Anjali Patel
Publikováno v:
ANTIVIRAL THERAPY
Background Physiological changes during pregnancy can have a significant impact on antiretroviral pharmacokinetics (PK), which may result in reduced drug efficacy. Here we describe the PK of darunavir/ritonavir (DRV/r) 800/100 once daily in a cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1c5e6ef359957f5e60104d2bf89476
https://pubmed.ncbi.nlm.nih.gov/30728322
https://pubmed.ncbi.nlm.nih.gov/30728322